Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6253
Rank
NZ$1.11 B
Marketcap
$55.65
Share price
0.33%
Change (1 day)
N/A
Change (1 year)

Revenue for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

Revenue in 0 (TTM): N/A

.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avalon Pharma (Middle East Pharmaceutical) from to

Annual revenue

Year Revenue Change